AU2003266086A1 - Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) - Google Patents
Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine)Info
- Publication number
- AU2003266086A1 AU2003266086A1 AU2003266086A AU2003266086A AU2003266086A1 AU 2003266086 A1 AU2003266086 A1 AU 2003266086A1 AU 2003266086 A AU2003266086 A AU 2003266086A AU 2003266086 A AU2003266086 A AU 2003266086A AU 2003266086 A1 AU2003266086 A1 AU 2003266086A1
- Authority
- AU
- Australia
- Prior art keywords
- cytokine
- lymphocytic leukemia
- chronic lymphocytic
- combination treatment
- cll cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41120402P | 2002-09-16 | 2002-09-16 | |
US60/411,204 | 2002-09-16 | ||
PCT/CA2003/001408 WO2004024171A1 (en) | 2002-09-16 | 2003-09-15 | Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003266086A1 true AU2003266086A1 (en) | 2004-04-30 |
Family
ID=31994247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003266086A Abandoned AU2003266086A1 (en) | 2002-09-16 | 2003-09-15 | Chronic lymphocytic leukemia combination treatment (treated cll cells and cytokine) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003266086A1 (en) |
WO (1) | WO2004024171A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2653020B1 (en) * | 1989-10-17 | 1993-03-26 | Roussel Uclaf | USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEUKEMIA. |
CA2324199A1 (en) * | 2000-10-25 | 2002-04-25 | Vasogen Ireland Limited | Chronic lymphocytic leukemia treatment |
-
2003
- 2003-09-15 WO PCT/CA2003/001408 patent/WO2004024171A1/en not_active Application Discontinuation
- 2003-09-15 AU AU2003266086A patent/AU2003266086A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004024171A1 (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003227235A1 (en) | Treating device, electrode, electrode plate, and treating method | |
AU2003213768A1 (en) | Use of benzimidazole analogs in the treatment of cell proliferation | |
AU2003254689A1 (en) | Table, especially conference and office table | |
AU2003254688A1 (en) | Table, especially office and conference table | |
AU2003233713A1 (en) | Systems and methods for channel allocation for forward-link in multi-user systems | |
IL174796A0 (en) | Methods for treating viral infection using-il-28 and il-29 | |
AU2003229027A1 (en) | Hydrocarbon-terminated polyether-polyamide block copolymers and uses thereof | |
AU2003239473A1 (en) | Fluid-assisted medical devices, systems and methods | |
AU2003267255A1 (en) | Methods and devices for active bioassay | |
AU2003285447A1 (en) | Transparent polyamide block and polyether block copolymers | |
AU2003248773A1 (en) | Ballast water treatment systems including related apparatus and methods | |
AU2003206012A1 (en) | Rate allocation and control for multicast services in wireless networks | |
AU2003286945A1 (en) | Plasma reactor and electrode plate used in the same | |
AU2003285139A1 (en) | Heat treated high density structures | |
EP1510819A4 (en) | Bioassay unit and substrate for bioassay | |
AU2003214798A1 (en) | Laminates and processes for making same | |
AU2003268032A1 (en) | Composition and methods for treatment and screening | |
AU2002332224A1 (en) | Arrangement and method for electrochemical purification or treatment | |
HK1080749A1 (en) | Purified cytokine inhibitory factor | |
AU2002338191A1 (en) | Surface treatment system and surface treatment method | |
AU2003220541A1 (en) | Gravity-fed in-line continuous processing system and method | |
AU2002258857A1 (en) | Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling | |
AU2002318711A1 (en) | Controllable released suppository used in milk-secreting channel | |
AU2003227987A1 (en) | Machining apparatus and methods | |
AU2003268376A1 (en) | Transdermal delivery systems and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |